1,5-anhydroglucitol has been researched along with thiazolidines in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoki, C; Aso, Y; Kato, K; Niitani, M; Suzuki, K; Tanaka, S; Tomotsune, T | 1 |
| Ako, J; Fujiyoshi, K; Hashikata, T; Hashimoto, T; Kakizaki, R; Kameda, R; Kitasato, L; Maekawa, E; Namba, S; Nemoto, T; Shimohama, T; Tojo, T; Yamaoka-Tojo, M | 1 |
2 other study(ies) available for 1,5-anhydroglucitol and thiazolidines
| Article | Year |
|---|---|
Add-on treatment with teneligliptin ameliorates glucose fluctuations and improves glycemic control index in Japanese patients with type 2 diabetes on insulin therapy.
Topics: Aged; C-Reactive Protein; Combined Modality Therapy; Deoxyglucose; Diabetes Mellitus, Type 2; Diet, Diabetic; Dipeptidyl-Peptidase IV Inhibitors; Drug Resistance; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Insulin; Japan; Male; Middle Aged; Monitoring, Ambulatory; Pilot Projects; Prospective Studies; Pyrazoles; Serum Albumin; Thiazolidines | 2014 |
Teneligliptin improves left ventricular diastolic function and endothelial function in patients with diabetes.
Topics: Adiponectin; Aged; Deoxyglucose; Diabetes Mellitus, Type 2; Diastole; Dipeptidyl-Peptidase IV Inhibitors; Echocardiography; Endothelium, Vascular; Female; Glycated Hemoglobin; Humans; Japan; Linear Models; Male; Middle Aged; Pyrazoles; Thiazolidines; Ventricular Function, Left | 2016 |